Santa Fe, NM, United States of America

John D MacCuish


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John D. MacCuish: Innovator in Artificial Intelligence and Chemistry

Introduction

John D. MacCuish is a notable inventor based in Santa Fe, NM (US), recognized for his contributions to the field of artificial intelligence and its application in chemistry. With a focus on enhancing the drug discovery process, MacCuish has developed innovative methods that bridge the gap between computational science and pharmaceutical development.

Latest Patents

MacCuish holds a patent for a "Method and system for artificial intelligence directed lead discovery through multi-domain agglomerative clustering." This patent describes a system designed to assist chemists in identifying pharmacophoric mechanisms based on a comprehensive set of input data representing various chemical compounds. The system utilizes agglomerative clustering to organize molecular representations according to their feature characteristics, resulting in a multi-domain pyramid structure. Each node within this structure represents one or more molecules, allowing for the identification of representative feature sets and activity levels. This innovative approach transforms extensive raw data into a format that is both understandable and commercially valuable, aiding chemists in the development of new pharmaceuticals.

Career Highlights

MacCuish is currently employed at Bioreason, Inc., where he applies his expertise in artificial intelligence to advance the field of drug discovery. His work is instrumental in creating systems that streamline the identification of potential pharmaceutical leads, thereby enhancing the efficiency of the research process.

Collaborations

One of MacCuish's notable collaborators is Christodoulos A. Nicolaou, a distinguished chemist known for his work in synthetic organic chemistry. Their collaboration exemplifies the integration of artificial intelligence with traditional chemistry, paving the way for innovative solutions in drug development.

Conclusion

John D. MacCuish's contributions to the intersection of artificial intelligence and chemistry highlight the potential for technology to revolutionize the pharmaceutical industry. His innovative patent and ongoing work at Bioreason, Inc. demonstrate a commitment to advancing drug discovery processes, ultimately benefiting the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…